Immunohistochemistry of Estrogen and Progesterone Receptors Reconsidered-Reference-Cited by-同舟云学术

Immunohistochemistry of Estrogen and Progesterone Receptors Reconsidered

Published:2005-01 Issue:1 Volume:123 Page:21-27
ISSN:0002-9173
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:Am J Clin Pathol

Author:

Nadji Mehrdad,Gomez-Fernandez Carmen,Ganjei-Azar Parvin,Morales Azorides R.

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/123/1/21/4986816/ajcpath123-0021.pdf

Reference16 articles.

1. Prognostic and predictive factors in breast cancer by immunohistochemical analysis;Allred, DC;Mod Pathol,1998

2. Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients;Barnes, DM;Br J Cancer,1996

3. Estrogen receptor status (ER) determined by immunohistochemistry (IHC) is superior to biochemical ligand-binding (LB) assay for evaluating breast cancer patients [abstract];Clark, GM;Proc ASCO,1997

4. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer;Harvey, JM;J Clin Oncol,1999

5. A new immunohisto-chemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples;Goulding, H;Hum Pathol,1995

Cited by 360 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reporting Hormone Receptor Expression in Breast Carcinomas: Which Method has the Highest Prognostic Power and What Should be the Optimal Cut-off Value?;International Journal of Surgical Pathology;2024-09-08

2. The vitamin D analog EB1089 sensitizes triple-negative breast cancer cells to the antiproliferative effects of antiestrogens;Advances in Medical Sciences;2024-09

3. Synthesis, In vitro and In silico Studies of Novel Bis‐triazolopyridopyrimidines from Curcumin Analogues as Potential Aromatase Agents;Chemistry & Biodiversity;2024-07-21

4. A holistic review of recent advances in nano-based drug delivery systems for the treatment of triple-negative breast cancer (TNBC);Journal of Nanoparticle Research;2024-05

5. Non-vesicular nanocarriers for breast cancer management: current advances, challenges, and future perspective;International Journal of Polymeric Materials and Polymeric Biomaterials;2024-04-24